Laster Morris C 13D/13G Filings for Scopus BioPharma Inc. (SCPS)

Laster Morris C 13D and 13G filings for Scopus BioPharma Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2021-05-11
6:58 pm
Purchase
2021-05-1013DSCOPUS BIOPHARMA INC
SCPS
Laster Morris C6,006,000
40.100%
1,080,000increase
(+21.92%)
Filing